APA (7th ed.) Citation

S, P., I, K., C, H., M, G., F, S., K, B., . . . T, S. (2023). LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition. EMBO molecular medicine, 15(12), e17719. https://doi.org/10.15252/emmm.202317719

Chicago Style (17th ed.) Citation

S, Proteau, et al. "LKB1-SIK2 Loss Drives Uveal Melanoma Proliferation and Hypersensitivity to SLC8A1 and ROS Inhibition." EMBO Molecular Medicine 15, no. 12 (2023): e17719. https://doi.org/10.15252/emmm.202317719.

MLA (9th ed.) Citation

S, Proteau, et al. "LKB1-SIK2 Loss Drives Uveal Melanoma Proliferation and Hypersensitivity to SLC8A1 and ROS Inhibition." EMBO Molecular Medicine, vol. 15, no. 12, 2023, p. e17719, https://doi.org/10.15252/emmm.202317719.